| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.68 | 0.008 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |